FDA Clears First COVID-19 Home Antigen Test

November 10, 2023 by Dan McCue
FDA Clears First COVID-19 Home Antigen Test
(Photo courtesy ACON Laboratories)

WASHINGTON — The Food and Drug Administration has approved the sale of the first over-the-counter antigen test for COVID-19.

The product, ACON Laboratories’ Flowflex COVID-19 Antigen Home Test, originally authorized for emergency use in 2021, is now the second home COVID-19 test to successfully complete a traditional FDA premarket review pathway.

In June the agency granted “market authorization” for the Cue COVID-19 Molecular Test. 

That product is a molecular nucleic acid amplification test that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. 

The FDA’s latest approval, announced Thursday, also marks the first time the test has been approved for use in children under 18. Today’s announcement follows clearance of a molecular home test earlier this year.

Dr. Jeff Shuren, J.D., director of the FDA’s Center for Devices and Radiological Health, said Thursday’s decision was part of an ongoing effort by the agency to help test developers provide consumers with additional options for safe and effective at-home COVID tests.

“The FDA continues to proactively work with test developers that desire to market their products beyond emergency use authorities. This is part of the FDA’s broader effort to advance the development and availability of at-home tests for a variety of medical conditions to expand patient access to testing,” Shuren said in a written statement.

The Flowflex COVID-19 Antigen Home Test is a visually read test cleared for OTC home use for symptomatic individuals within six days of symptom onset. 

The FDA said it can be used by individuals aged 14 years or older to test themselves, or by adults testing individuals aged two years or older.

In a study reviewed by the FDA, the Flowflex COVID-19 Antigen Home Test correctly identified 89.8% of positive and 99.3% of negative samples in individuals with signs and symptoms of upper respiratory infection. 

The agency went on to say that, as with antigen tests authorized for emergency use, the Flowflex test is intended to be used at least twice over three days with at least 48 hours between tests. 

“This means that a symptomatic individual with an initial negative test result should be re-tested once between 48 and 72 hours after the first test using an antigen test for COVID-19 or followed up with a molecular COVID-19 test,” the FDA explained in the release announcing its decision.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue

A+
a-
  • COVID-19
  • FDA
  • Flowflex
  • over-the-counter
  • In The News

    Health

    Voting

    In The News

    July 15, 2025
    by Sydney Devory
    DC Schools Prioritize Free Meals for Students

    WASHINGTON — The District of Columbia is committed to providing free meals for students in need despite challenges created by... Read More

    WASHINGTON — The District of Columbia is committed to providing free meals for students in need despite challenges created by recent legislation. Seven million children are predicted to lose eligibility for free school lunches due to SNAP and Medicaid cuts in the Republicans' recently passed policy... Read More

    Nextdoor Social Site, Looking for a Revival, Pins Hopes on Local News Providers

    NEW YORK (AP) — Nextdoor, the social media site that aims to create connections among neighbors, is trying to shake... Read More

    NEW YORK (AP) — Nextdoor, the social media site that aims to create connections among neighbors, is trying to shake off an uneven past and a nagging sense it is being underutilized. How? It is turning to professional journalists for help. The company announced a partnership... Read More

    Heavy Rains and Flash Flooding Sweep Across the Northeast

    NEW YORK (AP) — Heavy rain swept across parts of the U.S. Northeast on Monday night, inundating sections of New... Read More

    NEW YORK (AP) — Heavy rain swept across parts of the U.S. Northeast on Monday night, inundating sections of New York and New Jersey with flash flooding that stranded vehicles in roadways, closed subway lines and led to a declaration of a state of emergency. Most... Read More

    July 14, 2025
    by Dan McCue
    Supreme Court Green-Lights Dismantling of Education Department

    WASHINGTON — In a major victory for the Trump administration, the Supreme Court ruled on Monday that the White House... Read More

    WASHINGTON — In a major victory for the Trump administration, the Supreme Court ruled on Monday that the White House can move forward with plans to lay off nearly 1,400 employees at the Department of Education. As is their custom in dispensing with emergency orders, the... Read More

    July 14, 2025
    by Dan McCue
    Trump Gives Russia Ultimatum, Seeks Ukraine Deal in 50 Days

    WASHINGTON — President Donald Trump gave Russian President Vladimir Putin a stiff ultimatum on Monday, threatening Russia with crippling new... Read More

    WASHINGTON — President Donald Trump gave Russian President Vladimir Putin a stiff ultimatum on Monday, threatening Russia with crippling new tariffs if he does not end his war with Ukraine within the next 50 days. In addition the president announced the creation of a new weapons... Read More

    July 14, 2025
    by Tom Ramstack
    Appeals Court Allows Defense Dept. to Override Sept. 11 Conspirators’ Deal

    WASHINGTON — A federal appeals court’s ruling Friday allows the federal government to set aside a plea bargain that would... Read More

    WASHINGTON — A federal appeals court’s ruling Friday allows the federal government to set aside a plea bargain that would spare conspirators in the Sept. 11, 2001, attack on the United States from the death penalty. The plea bargain was reached in August with Khalid Sheikh... Read More

    News From The Well
    scroll top